Cancer is
characterized by rapid cell division/growth.
The ability of chemotherapy to kill cancer cells depends on its ability
to halt cell division. Usually, the
drugs work by damaging the RNA or DNA that tells the cell how to copy itself in
division. If the cells are unable to
divide, they die. Chemotherapy is most
effective at killing cells that are rapidly dividing. Unfortunately, chemotherapy does not know the
difference between the cancerous cells and the normal cells. The “normal” cells will grow back and be
healthy, but in the meantime side effects occur. The “normal” cells most commonly affected by
chemotherapy are also cells that divide and copy quickly – blood cells, cells
in the mouth, stomach and bowel, and the hair follicles; resulting in low blood
counts, mouth sores, nausea, diarrhea, and/or hair loss.
Jess and I attended Chemo class this past Wednesday. This 2-hour class is conducted by an oncology
RN for patients and caregivers. We each
got an individualized loose-leaf binder with info on our specific chemo
drugs. Here are mine:
Taxotere is an
anti-cancer (“antineoplastic” or “cytotoxic”) chemotherapy drug. Taxotere is classified as a “plant alkaloid,”
a “taxane” and an “antimicrotuble” agent.
It’s given intravenously.
Premedication with a corticosteroid pill starting a day prior to Taxotere
infusion for 3 days is given to reduce the severity of fluid retention and
allergic reactions. Common side effects:
·
Low white blood cell count (increased risk of
infection)
·
Low red blood cell count (anemia)
·
Nadir: Meaning low point, nadir is the point in
time between chemotherapy cycles in which you experience low blood counts.
o
Onset: 4-7 days
o
Nadir: 5-9 days
o
Recovery: 21 days
·
Fluid retention
·
Peripheral neuropathy (numbness in fingers and
toes)
·
Nausea
·
Diarrhea
·
Mouth sores
·
Hair loss
·
Fatigue and weakness
·
Infection
·
Nail changes
The process of cell division, whether normal or cancerous
cells, is through the cell cycle. The
cell cycle goes from the resting phase, through active growing phases, and then
to mitosis (division). Chemotherapy
drugs that affect cells only when they are dividing are called cell-cycle
specific. Chemotherapy drugs that affect
cells when they are at rest are called cell-cycle non-specific. The scheduling of chemotherapy is set based
on the type of cells, rate at which they divide, and the time at which a given
drug is likely to be effective. This is
why chemotherapy is typically given in cycles.
Taxotere belongs to a class of chemotherapy drugs called
plant alkaloids, and is cell-cycle specific.
This means it attacks the cells during various phases of division. Antimicrotubule agents inhibit the
microtubule structures within the cell.
Microtubules are part of the cell’s apparatus for dividing and
replicating itself. Inhibition of these
structures ultimately results in cell death.
Cytoxan is an
anti-cancer (“antineoplastic” or “cytotoxic”) chemotherapy drug. Cytoxan is classified as an “alkylating
agent.” Usually given by intravenous,
the following side effects are common:
·
Low blood counts (white and red blood cells and
platelets) – increased risk for infection, anemia and/or bleeding.
·
Nadir:
o
Onset: 7 days
o
Nadir: 10-14 days
o
Recovery: 21 days
·
Hair loss
·
Nausea and vomiting
·
Poor appetite
·
Loss of fertility
Cytoxan is classified as an alkylating agent, most active in
the resting phase of the cell. This drug
is cell-cycle non-specific.
Non-chemotherapy
Drugs:
Neulasta is a
biologic response modifier. It is
classified as a colony stimulating factor used to stimulate the growth of “healthy”
white blood cells in the bone marrow, once chemotherapy is given. White blood
cells help the body fight infection. This is not a chemotherapy drug. It is usually given at least 24 hours after
chemotherapy to stimulate the growth of new, healthy, white blood cells (WBC),
and is given via injection.
Dexamethasone –
corticosteroid used to mitigate fluid retention, allergies, arthritis, asthma
and skin conditions.
Prochlorperazine –
used to control severe nausea and vomiting.
###
No comments:
Post a Comment